YS-IL6

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameYS-IL6
Drug Alias NameAnfil6YSIL6-O-RAYSIL-6YSIL6-T-PSYS-IL6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-6 inhibitorsTumor necrosis factor α inhibitors
TargetsInterleukin-6Tumor necrosis factor α
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesY'S Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesY'S Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A